Cambridge Investment Research Advisors’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
+183,534
| New | +$292K | ﹤0.01% | 3002 |
|
|
2023
Q4 | – | Sell |
-2,184
| Closed | -$37K | – | 3211 |
|
|
2023
Q3 | $37K | Hold |
2,184
| – | – | ﹤0.01% | 3060 |
|
|
2023
Q2 | $66K | Hold |
2,184
| – | – | ﹤0.01% | 3059 |
|
|
2023
Q1 | $64K | Hold |
2,184
| – | – | ﹤0.01% | 3009 |
|
|
2022
Q4 | $43K | Hold |
2,184
| – | – | ﹤0.01% | 2995 |
|
|
2022
Q3 | $66K | Hold |
2,184
| – | – | ﹤0.01% | 2913 |
|
|
2022
Q2 | $50K | Sell |
2,184
-11
| -0.5% | -$252 | ﹤0.01% | 2942 |
|
|
2022
Q1 | $98K | Hold |
2,195
| – | – | ﹤0.01% | 3012 |
|
|
2021
Q4 | $85K | Buy |
+2,195
| New | +$85K | ﹤0.01% | 3051 |
|